Practical Recommendations for the Allergological Risk Assessment of the COVID-19 Vaccination - a Harmonized Statement of Allergy Centers in Germany

Overview

Journal Allergol Select

Specialty Allergy & Immunology

Date 2021 Feb 1

PMID 33521511

Citations 14

Authors

Margitta Worm

Andrea Bauer

Bettina Wedi

Regina Treudler

Wolfgang Pfuetzner

Knut Brockow

Timo Buhl

Torsten Zuberbier

Joachim Fluhr

Gerda Wurpts

Ludger Klimek

Thilo Jakob

Hans F Merk

Norbert Mulleneisen

Stefani Roeseler

Heinrich Dickel

Ulrike Raap

Jorg Kleine-Tebbe

Affiliations

Soon will be listed here.

Abstract

Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.

Citing Articles

[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases].

Villar-Alvarez F, Martinez-Garcia M, Jimenez D, Farinas-Guerrero F, Ortiz de Lejarazu-Leonardo R, Lopez-Campos J Open Respir Arch. 2024; 3(2):100097.

PMID: 38620748 PMC: 7983358. DOI: 10.1016/j.opresp.2021.100097.

[Experiencia en la vacunación frente a la COVID-19 en personas con antecedentes de alergia.].

Garcia Vicente J, Vedia Urgell C, Valles Fernandez R, Morgado Ramos C, Moral Roldan E, Marchal Torralbo S Rev Esp Salud Publica. 2023; 97.

PMID: 37970964 PMC: 10558102.

SARS-CoV-2 and allergy - what have we learned after two and a half years?.

Brockow K, Wang R, Mathes S, Bent R, Faihs V, Eberlein B Allergol Select. 2023; 7:101-112.

PMID: 37056446 PMC: 10088874. DOI: 10.5414/ALX02373E.

Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema.

Mormile I, Gigliotti M, Petraroli A, Cocchiaro A, Furno A, Granata F Vaccines (Basel). 2023; 11(2).

PMID: 36851094 PMC: 9962435. DOI: 10.3390/vaccines11020215.

Vaccinating with a COVID-19 Vaccine: Experience of the Tertiary Allergology Center.

Zilenaite E, Malinauskiene L, Cerniauskas K, Griguola L, Linauskiene K, Kvedariene V Acta Med Litu. 2022; 29(1):27-32.

PMID: 36061933 PMC: 9428637. DOI: 10.15388/Amed.2021.29.1.1.

References

Perino E, Freymond N, Devouassoux G, Nicolas J, Berard F . Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate. Ann Allergy Asthma Immunol. 2018; 120(6):664-666. DOI: 10.1016/j.anai.2018.02.018. View

Inglut C, Sorrin A, Kuruppu T, Vig S, Cicalo J, Ahmad H . Immunological and Toxicological Considerations for the Design of Liposomes. Nanomaterials (Basel). 2020; 10(2). PMC: 7074910. DOI: 10.3390/nano10020190. View

. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020. MMWR Morb Mortal Wkly Rep. 2021; 70(2):46-51. PMC: 7808711. DOI: 10.15585/mmwr.mm7002e1. View

McNeil M, Weintraub E, Duffy J, Sukumaran L, Jacobsen S, Klein N . Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2015; 137(3):868-78. PMC: 4783279. DOI: 10.1016/j.jaci.2015.07.048. View

Kleine-Tebbe J, Klimek L, Hamelmann E, Pfaar O, Taube C, Wagenmann M . Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences. Allergol Select. 2021; 5:26-28. PMC: 7787363. DOI: 10.5414/ALX02215E. View

Sellaturay P, Nasser S, Ewan P . Polyethylene Glycol-Induced Systemic Allergic Reactions (Anaphylaxis). J Allergy Clin Immunol Pract. 2020; 9(2):670-675. DOI: 10.1016/j.jaip.2020.09.029. View

Zhou Z, Stone Jr C, Jakubovic B, Phillips E, Sussman G, Park J . Anti-PEG IgE in anaphylaxis associated with polyethylene glycol. J Allergy Clin Immunol Pract. 2020; 9(4):1731-1733.e3. PMC: 8090930. DOI: 10.1016/j.jaip.2020.11.011. View

Kato M, Oiso N, Uchida S, Yanagihara S, Sano H, Tohda Y . Biologic-induced urticaria due to polysorbate 20. J Dermatol. 2019; 46(7):e230-e232. DOI: 10.1111/1346-8138.14808. View

Worm M, Ring J, Klimek L, Jakob T, Lange L, Treudler R . [Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management]. MMW Fortschr Med. 2021; 163(1):48-51. PMC: 7814269. DOI: 10.1007/s15006-021-9530-6. View

10.

Wenande E, Garvey L . Immediate-type hypersensitivity to polyethylene glycols: a review. Clin Exp Allergy. 2016; 46(7):907-22. DOI: 10.1111/cea.12760. View

11.

Bruusgaard-Mouritsen M, Johansen J, Garvey L . Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients. Clin Exp Allergy. 2021; 51(3):463-470. DOI: 10.1111/cea.13822. View

12.

Stone Jr C, Liu Y, Relling M, Krantz M, Pratt A, Abreo A . Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. J Allergy Clin Immunol Pract. 2018; 7(5):1533-1540.e8. PMC: 6706272. DOI: 10.1016/j.jaip.2018.12.003. View

13.

Kraft M, Renaudin J, Ensina L, Kleinheinz A, Bilo M, Scherer Hofmeier K . Anaphylaxis to vaccination and polyethylene glycol: a perspective from the European Anaphylaxis Registry. J Eur Acad Dermatol Venereol. 2021; 35(10):e659-e662. PMC: 8242778. DOI: 10.1111/jdv.17327. View

14.

Kozma G, Shimizu T, Ishida T, Szebeni J . Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv Drug Deliv Rev. 2020; 154-155:163-175. DOI: 10.1016/j.addr.2020.07.024. View